Tikun Olam Holdings
Wilmington
About Tikun Olam Holdings
A leading cannabis brand and globally recognized as the pioneer of modern medical cannabis. The company’s global mission is to research, develop and provide efficacious, data-based cannabis treatments to help sufferers. Operating as a commercial venture for over ten years, Tikun Olam’s products have been used since 2010 in ongoing clinical trials in Israel’s regulated medical cannabis market, treating over 10,000 patients for a variety of symptoms of medical conditions such as Cancer, PTSD, AIDS, epilepsy, Crohn’s Disease/Colitis, multiple sclerosis, cerebral palsy, chronic pain and neuropathy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: Seed
- Last round: Convertible Note (Nov 2018)
- Website: tikunolamusa.com
- Phone: 302.543.2100
Industries & Categories
Biotechnology, Cannabis, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tikun-olam-holdings-145487 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.